decreased smooth muscle cell proliferation reduces neointimal formation Anti-inflammatory signaling: Suppression of NF-kB, reduced macrophage infiltration into plaques, and decreased secretion of IL-6, TNF-alpha, and MCP-1 from monocytes and foam cells Atherogenic lipid reduction: Improvements in LDL cholesterol, VLDL, triglycerides, and chylomicron remnants beyond what weight loss alone would predict Blood pressure reduction: Through direct vasodilation and natriuresis, independent of weight change Epicardial and perivascular fat reduction: This fat depot exerts direct paracrine inflammatory effects on the vascular endothelium and myocardium
With Wegovy, Mounjaro, and Zepbound, each pen is for a single use
Here is a full week of GLP-1 friendly meals that hits protein targets, manages side effects, and requires minimal cooking through strategic meal prep
A dedicated Phase 2b trial in MASLD and MASH patients is ongoing